Literature DB >> 940293

[Histocompatibility-(HLA) antigens in patients with HBsAg positive and negative hepatitis and healthy carriers of HBsAg and anti-HBs. (author's transl)].

J Freudenberg, K H Meyer zum Büschefelde, W Arnold, J Berger, H Weiller, J Knolle, U Hopf, T Hütteroth.   

Abstract

New own data and a survey of published data concerning the frequencies of 23 HLA antigens in patients with HBsAg positive and negative chronic active hepatitis (CAH) and healthy carriers of Hepatitis-surface antigen (HBsAg) and high titers of antibodies to HBaAg (Anti-HBs) allow to conclude as follows: 1. Patients with CAH and persistence of HBsAg show a normal frequency of HLA-B8. 2. There is no increased frequency of HLA-B8 in HBsAg negative CAH without autoimmune antibodies. 3. Only in patients with HBsAg negative CAH with autoimmune antibodies is the frequency of HLA-B8 is statistically significantly increased (p less than 0.01 after correction for the number of antigens and different groups of patients compared). These are patients with the autoimmune form of CAH. 4. There exist no significant differences in the frequencies of the HLA antigens tested in patients with HBsAg positive CAH and healthy carriers of HBsAg and Anti-HBs. Thus no indications could be found for HLA-associated factors in the different behaviour to the hepatitis-B virus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940293     DOI: 10.1007/bf01619573

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16.

Authors:  M J Spencer; J D Cherry; P I Terasaki
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

2.  Representative HL-A phenotype and haplotype frequencies of the german population.

Authors:  E D Albert; S Scholz; J Bertrams; R W Ewald; E Westphal; K W Ratschko; W Spielmann; S Seidl
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-05

3.  Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis.

Authors:  R M Galbraith; A L Eddleston; M G Smith; R Williams; R N McSween; G Watkinson; H Dick; L A Kennedy; J R Batchelor
Journal:  Br Med J       Date:  1974-09-07

4.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

5.  An association of HL-A3 and HL-A7 with paralytic poliomyelitis.

Authors:  M C Pietsch; P J Morris
Journal:  Tissue Antigens       Date:  1974

6.  [HL-A in liver diseases (author's transl)].

Authors:  J Freudenberg; K Erdmann; E Förster; J Berger
Journal:  Klin Wochenschr       Date:  1973-11

7.  Letter: HL-A antigens in asymptomatic chronic HBAg carriers.

Authors:  M Jeannet; J J Farquet
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

8.  [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].

Authors:  J Bertrams; E Kuwert; H E Reis; H Selmair; W Wiese
Journal:  Zentralbl Bakteriol Orig A       Date:  1974

9.  Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases.

Authors:  K H Meyer zum Büschenfelde; A Alberti; W Arnold; J Freudenberg
Journal:  Klin Wochenschr       Date:  1975-11-15

10.  Genetic analysis of patients with chronic active hepatitis.

Authors:  A R Page; H L Sharp; L J Greenberg; E J Yunis
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.